By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
All-In PodcastE35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
Episode Details
EPISODE INFO
- Released
- June 13, 2021
- Duration
- 1h 35m
- Channel
- All-In Podcast
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
Follow the besties: https://twitter.com/chamath https://linktr.ee/calacanis https://twitter.com/DavidSacks https://twitter.com/friedberg Follow the pod: https://twitter.com/theallinpod https://linktr.ee/allinpodcast Show Notes: 0:00 Bestie intro, Chamath's whereabouts 2:54 Breaking down Biogen's Alzheimer's drug & the FDA's controversial approval 26:46 Billionaire space race: Is Bezos going to space too risky or a smart marketing move? How the space industry is a perfect example of effective government intervention. Can anyone dominate space? 42:55 Big Tech getting back to the office: what is the new normal for companies with thousands of employees? 56:49 Recent factors on the commercial & private real estate markets, inflation head fake 1:05:01 ProPublica's report on billionaire tax returns 1:15:58 Bitcoin toxicity, Snowflake's CEO apologizes for comments on merit & diversity 1:32:48 Science corner with Friedberg: Induced pluripotent stem cells & cloning Intro Music Credit: https://rb.gy/tppkzl https://twitter.com/yung_spielburg Referenced in the show: https://www.statnews.com/2021/06/07/fda-grants-historic-approval-to-alzheimers-drug-designed-to-slow-cognitive-decline/ https://www.bloomberg.com/news/articles/2021-06-10/harvard-expert-quits-fda-panel-as-furor-over-biogen-drug-grows https://www.instagram.com/p/CP0MSOqnYEo https://www.wsj.com/articles/facebook-lets-more-employees-choose-full-time-remote-work-or-return-to-the-office-11623258049 https://news.yahoo.com/salesforce-ceo-marc-benioff-on-slack-acquisition-135151402.html https://socketsite.com/archives/2021/04/visualizing-all-the-vacant-office-space-in-san-francisco.html https://www.wsj.com/articles/if-you-sell-a-house-these-days-the-buyer-might-be-a-pension-fund-11617544801 https://fred.stlouisfed.org/series/T10YIE https://www.propublica.org/article/the-secret-irs-files-trove-of-never-before-seen-records-reveal-how-the-wealthiest-avoid-income-tax https://www.aqr.com/Insights/Research/Journal-Article/Buffetts-Alpha https://www.ft.com/content/42daca9e-facc-11e7-9bfc-052cbba03425 https://www.bloomberg.com/news/articles/2021-06-07/snowflake-ceo-offers-apologies-support-for-hiring-diversity Tweets: https://twitter.com/Jason/status/1401938511826067457 https://twitter.com/elonmusk/status/1386825367948644352 https://twitter.com/micsolana/status/1403394491143315456 https://twitter.com/Jason/status/1403023180709580801
SPEAKERS
Jason Calacanis
hostDavid Sacks
hostDavid Friedberg
hostChamath Palihapitiya
hostNarrator
otherNarrator
otherNarrator
other
EPISODE SUMMARY
In this episode of All-In Podcast, featuring Jason Calacanis and David Sacks, E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more explores Alzheimer’s drug uproar, billionaire space race, and economic fault lines This All-In Podcast episode spans Biogen’s controversial Alzheimer’s drug approval, the billionaire-led private space race, post-pandemic work-from-home battles, the housing and inflation crunch, and tax fairness debates. The besties unpack how weak efficacy but strong financial incentives shaped the aducanumab decision and what it reveals about FDA, Medicare, and pharma. They then dive into Bezos vs. Branson vs. SpaceX as a test case for public–private innovation, before shifting to remote work, commercial real estate, and structural problems in housing supply and inflation. The conversation closes with IRS tax leaks, wealth creation mechanics, meritocracy vs. diversity fights, China’s 9-9-6 work culture, and the social psychology behind Bitcoin maximalism.
RELATED EPISODES
